BIO X6
Bioprinter
The BIO X6 3D bioprinter enables the fabrication of multi-material constructs used in cell culture workflows for drug development, tissue engineering, and regenerative medicine. An intuitive design and additional printheads make the BIO X6 the most user-friendly bioprinter on the market, building on the previous gold standard established by the BIO X™. With six printhead slots and unparalleled flexibility in its configuration, the BIO X6 allows researchers to adapt the system to their research, quickly validating, testing, and building on new ideas.
iF Gold Statement
Highly professional, non-obtrusive and focused perfectly on the users needs: this bioprinter speeds up drug development and tissue engineering. The result is less animal testing, improved novel drug testing and lower costs. Six movable printheads guarantee major flexibility. A remarkable innovation!
Date of Launch
2020
Development Time
13 - 24 months
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Other target groups: Scientists, Cell biologists